Dr. Adams et al., PREPARATION AND ANTI-HIV ACTIVITY OF N-3-SUBSTITUTED THYMIDINE NUCLEOSIDE ANALOGS, Journal of medicinal chemistry, 40(10), 1997, pp. 1550-1558
A series of 22 derivatives of AZT substituted at the N-3 position of t
he thymine base were prepared and evaluated for anti-HIV activity in c
ell culture (Lai strain of HIV-1 in CEM-c113 cells). The AZT analogs b
earing a N-3 amino group (7), a hydroxyalkyl chain (12f), and a phosph
onomethyl (12k) substituent displayed activities in the 0.045-0.082 mu
M range. The analogs 12d, 12e, 12q, 15, and 19 were active at <0.5 mu
M concentration. Compound 18 in which two molecules of AZT are connec
ted at N-3 via a two-carbon link and ''dimer'' II also displayed signi
ficant; activity. To obtain information concerning the mechanism of RT
inhibition by these AZT analogs, compounds 7, 12d, 12e, and 12q were
incubated with recombinant HIV-1 RT in the presence of poly(A)-oligo[d
T((12-18))] and poly(C)-oligo[dG((12-18))] template-primers. In contra
st to AZT-TP (control), none of these nucleosides displayed any signif
icant inhibition of RT in the recombinant enzyme assay, indicating tha
t phosphorylation is a necessary prerequiste for activity.